GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stemline Therapeutics Inc (NAS:STML) » Definitions » Days Inventory

Stemline Therapeutics (Stemline Therapeutics) Days Inventory : 180.79 (As of Mar. 2020)


View and export this data going back to 2013. Start your Free Trial

What is Stemline Therapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Stemline Therapeutics's Average Total Inventories for the three months ended in Mar. 2020 was $1.27 Mil. Stemline Therapeutics's Cost of Goods Sold for the three months ended in Mar. 2020 was $0.64 Mil. Hence, Stemline Therapeutics's Days Inventory for the three months ended in Mar. 2020 was 180.79.

The historical rank and industry rank for Stemline Therapeutics's Days Inventory or its related term are showing as below:

STML's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 190.305
* Ranked among companies with meaningful Days Inventory only.

Stemline Therapeutics's Days Inventory declined from Mar. 2019 (899.77) to Mar. 2020 (180.79).

Inventory Turnover measures how fast the company turns over its inventory within a year. Stemline Therapeutics's Inventory Turnover for the three months ended in Mar. 2020 was 0.50.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Stemline Therapeutics's Inventory-to-Revenue for the three months ended in Mar. 2020 was 0.14.


Stemline Therapeutics Days Inventory Historical Data

The historical data trend for Stemline Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stemline Therapeutics Days Inventory Chart

Stemline Therapeutics Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 85.86

Stemline Therapeutics Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 899.77 352.40 277.15 58.00 180.79

Competitive Comparison of Stemline Therapeutics's Days Inventory

For the Biotechnology subindustry, Stemline Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stemline Therapeutics's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stemline Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Stemline Therapeutics's Days Inventory falls into.



Stemline Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Stemline Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2019 is calculated as

Days Inventory (A: Dec. 2019 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2018 ) + Total Inventories (A: Dec. 2019 )) / count ) / Cost of Goods Sold (A: Dec. 2019 )*Days in Period
=( (0 + 1.151) / 1 ) / 4.893*365
=1.151 / 4.893*365
=85.86

Stemline Therapeutics's Days Inventory for the quarter that ended in Mar. 2020 is calculated as:

Days Inventory (Q: Mar. 2020 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2019 ) + Total Inventories (Q: Mar. 2020 )) / count ) / Cost of Goods Sold (Q: Mar. 2020 )*Days in Period
=( (1.151 + 1.389) / 2 ) / 0.641*365 / 4
=1.27 / 0.641*365 / 4
=180.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stemline Therapeutics  (NAS:STML) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Stemline Therapeutics's Inventory Turnover for the three months ended in Mar. 2020 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Stemline Therapeutics's Inventory to Revenue for the three months ended in Mar. 2020 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Stemline Therapeutics Days Inventory Related Terms

Thank you for viewing the detailed overview of Stemline Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Stemline Therapeutics (Stemline Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
750 Lexington Avenue, 11th Floor, New York, NY, USA, 10022
Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is involved in the business of discovering, acquiring and developing and commercializing therapeutics for oncology indications of unmet medical need. Its pipeline product candidates include felezonexor (SL-801, an XPO1 inhibitor), SL-1001 (a RET kinase inhibitor), SL-901 (a kinase inhibitor) and SL-701 (an immunotherapy). The company is also involved in advancing its clinical stage programs, expanding and strengthening its intellectual property portfolio, identifying and acquiring additional product and technology rights.
Executives
Darren S Cline director 35 CAMBRIDGE PARK DRIVE, CAMBRIDGE MA 02140
Kenneth J Zuerblis director 20 KINGSBRIDGE RD, PISCATAWAY NJ 08854
Daniel Hume director 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK NY 10019
Kenneth Hoberman officer: Chief Operating Officer 750 LEXINGTON AVENUE, 6TH FLOOR, NEW YORK NY 10024
Ron Bentsur director 750 LEXINGTON AVE, 20TH FL, NEW YORK NY 10022
Alan S Forman director 55 WHITNEY AVENUE, 5TH FLOOR, NEW HAVEN CT 06511
Eric Dobmeier director C/O SAETTLE GENETICS INC, 21823 30TH DRIVE SE, BOTHELL WA 98021
J Kevin Buchi director 41 MOORES ROAD, FRAZER PA 19355
Eric K Rowinsky officer: Chief Medical Officer IMCLONE SYSTEMS INCORPORATED, 180 VARICK STREET, 6TH FLOOR, NEW YORK NY 10014